Florida Retina Institute | North Florida - Jacksonville Southside
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
In this study researchers want to learn more about changes in visual acuity (clarity of vision) with a high dose treatment with Aflibercept (Eylea) in patients suffering from neovascular age-related macular degeneration (nAMD). Neovascular AMD is an eye disease that causes blurred vision or a blind spot due to abnormal blood vessels that leak fluid or blood into the light sensitive lining inside the eye (retina). The fluid buildup causes the central part of the retina (macula) responsible for sharp, straight-ahead vision to swell and thicken (edema), which distorts vision.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Additional inclusion criteria for Year 3:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
1,011 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal